SP140’s overexpression may enhance immune responses in the tumor microenvironment, while SP100’s downregulation disrupts differentiation via transcriptional/translational suppression, leading to initiation and progression of tumorigenesis [10, 25]. The gene discussed is SP140; the disease is neoplasm.